Kynam Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.8M | Sell |
|
|||||
|
2025
Q1 | $67M | Sell |
|
|||||
|
2024
Q4 | $68.3M | Hold |
|
|||||
|
2024
Q3 | $69M | Buy |
|
|||||
|
2024
Q2 | $54.5M | Buy |
|
|||||
|
2024
Q1 | $33.2M | Buy |
|
|||||
|
2023
Q4 | $27.6M | Buy |
|
|||||
|
2023
Q3 | $22.2M | Buy |
|
|||||
|
2023
Q2 | $20.1M | Buy |
|
|||||
|
2023
Q1 | $8.34M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $5.48M | Sell |
|
|||||
|
2022
Q2 | $9.91M | Buy |
|